Unit 1.4 Flashcards
the abnormal psychological and/or physical dependence on a drug
Addiction
drug name that reflects the chemical makeup of the drug
Chemical Name
scientific tests that research the efficacy and safety of a medication
Clinical trials
the use of an investigational new drug (IND) in patients who are suffering greatly and may die without the drug
Compassionate use
group of people in clinical trials who receive the placebo or usual treatment, in contrast to the group given the treatment or medication being studied
Control Group
a law enacted in 1971 to control the distribution and use of all depressant and stimulant drugs and other drugs of abuse or potential abuse
Controlled Substance Act
neither the patient nor the researcher in the clinical trial knows who has the placebo and who has the drug being tested
Double-blind
agency where substances monitored, designated, controlled and distributed that have the potential for abuse under U.S. Department of Justice 1970
Drug Enforcement Administration (DEA)
U.S. government agency responsible for regulation and supervision of food and medication to ensure the safety of the public’s health 1906 cosmetic 1938
Food and Drug Administration (FDA)
official name of the drug; nonproprietary
Generic name
a drug under development and in the first three phases of clinical trials
Investigational New Drug (IND)
manufacturer files this with the FDA following phase III success
New drug application (NDA)
inactive substance or treatment used as a nonspecific or inactive control in a test of a therapy that is suspected of being useful for a particular disease or condition; also, given to satisfy a patient’s demand for medicine
Placebo
misuse or improper use of medications
Substance abuse
